Instrumento Inactivo

Otros idiomas Anchiano Therapeutics Ltd.

Acciones

ANCN

US03280X1028

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	17/03/21
DJ Industrial : Wall Street Narrowly Mixed; Data, Fed Rate Meeting in Focus	16/03/21
Anchiano Therapeutics : Shareholders OK Pending Chemomab Merger	16/03/21
Anchiano Therapeutics Ltd.(NasdaqCM:ANCN) dropped from NASDAQ Composite Index	16/03/21
ChemomAb Ltd. completed the acquisition of Anchiano Therapeutics Ltd. in a reverse merger transaction.	16/03/21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing	15/03/21
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	10/03/21
ANCHIANO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	09/03/21
Anchiano Therapeutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	09/03/21
Anchiano Therapeutics Ltd. Auditor Raises 'Going Concern' Doubt	09/03/21
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	08/02/21
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN	16/01/21
ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	15/12/20
Anchiano Therapeutics : Chemomab Plan Merger to Advance Treatment for Fibrosis-Related Diseases	15/12/20
Anchiano Therapeutics : and Chemomab Announce Entry Into Definitive Merger Agreement	15/12/20
Anchiano Therapeutics Ltd. and Chemomab Ltd. Announce Executive Appointments	15/12/20
ChemomAb Ltd. entered into letter of intent to acquire Anchiano Therapeutics Ltd. for for $27.2 million in a reverse merger transaction.	15/12/20
Anchiano Therapeutics Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	16/11/20
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	16/11/20
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)	20/10/20

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Anchiano Therapeutics Ltd.

Acciones

ANCN

US03280X1028

Otros idiomas

Filtros